FDA Chief Marty Makary Discusses Compounded GLP-1s, Vaccines, and Agency Challenges

FDA chief Marty Makary addresses the contentious period for the agency, marked by significant staff and budget cuts, and discusses changes to vaccine policy and the use of compounded GLP-1s.

19 Feb, 19:52 — 19 Feb, 19:52

Post Share

Read at source (1 outlet)

cnbc1h ago

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping changes to vaccine policy.

Read full article →

PERSPECTA

FDA Chief Marty Makary Discusses Compounded GLP-1s, Vaccines, and Agency Challenges

Read at source (1 outlet)

Healthy Returns: FDA chief Marty Makary on compounded GLP-1s, vaccines and China

Related Stories

The Case for More Personalized Breast Cancer Screening

Indian Trail Tournament Promotes Mental Health Awareness for Young Athletes

Thyroid and Infection Drugs Receive New Safety Warnings Over Mental Health Risks

Skincare Solutions for Achieving Smooth, Bright Skin